COPD and the microbiome

Respirology

Volumn 21, Issue 4, 2016, Pages 590-599

  Mammen, Manoj J ^a   Sethi, Sanjay ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

16S Ribosomal RNA; 16S rRNA gene sequencing; chronic obstructive pulmonary disease; microbiome

Indexed keywords

BACTERIAL DNA; RNA 16S; ANTIINFECTIVE AGENT;

16S RRNA GENE; ACTINOBACTERIA; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; BACTEROIDETES; BIOINFORMATICS; BREAST CANCER; BRONCHOSCOPY; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DNA MICROARRAY; FIRMICUTES; HAEMOPHILUS; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOLOGY; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; LUNG CANCER; LUNG EMPHYSEMA; LUNG LAVAGE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; MICROFLORA; MORAXELLA; NASAL LAVAGE; NEISSERIACEAE; NEXT GENERATION SEQUENCING; NONHUMAN; OPERATIONAL TAXONOMIC UNIT; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; REVIEW; RNA GENE; SPECIES RICHNESS; SPUTUM ANALYSIS; STENOTROPHOMONAS; STOMACH LAVAGE; TAXONOMY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; DISEASE COURSE; FEMALE; GASTROINTESTINAL TRACT; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SMOKING; UNITED STATES;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LUNG; MICROBIOTA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; SMOKING; UNITED STATES;

EID: 84958818912     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12732     Document Type: Review

References (30)

1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE,. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
2. Chakravorty S, Helb D, Burday M, Connell N, Alland D,. A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. J. Microbiol. Methods 2007; 69: 330-339.
3. Aguirre E, Galiana A, Mira A, Guardiola R, Sanchez-Guillen L, Garcia-Pachon E, Santibanez M, Royo G, Rodriguez JC,. Analysis of microbiota in stable patients with chronic obstructive pulmonary disease. APMIS 2015; 123: 427-432.
4. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013; 31: 814-821.
5. Morgan XC, Huttenhower C,. Chapter 12: human microbiome analysis. PLoS Comput. Biol. 2012; 8: e1002808.
6. D'Onofrio A, Crawford JM, Stewart EJ, Witt K, Gavrish E, Epstein S, Clardy J, Lewis K,. Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem. Biol. 2010; 17: 254-264.
7. Wade W,. Unculturable bacteria-the uncharacterized organisms that cause oral infections. J. R. Soc. Med. 2002; 95: 81-83.
8. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5: e8578.
9. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG,. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 2011; 184: 957-963.
10. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, et al. Analysis of the lung microbiome in the 'healthy' smoker and in COPD. PLoS ONE 2011; 6: e16384.
11. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS,. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 173: 991-998.
12. Galiana A, Aguirre E, Rodriguez JC, Mira A, Santibanez M, Candela I, Llavero J, Garcinuno P, Lopez F, Ruiz M, et al. Sputum microbiota in moderate versus severe patients with COPD. Eur. Respir. J. 2014; 43: 1787-1790.
13. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A,. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur. Respir. J. 1999; 14: 1015-1022.
14. Rangelov K, Sethi S,. Role of infections. Clin. Chest Med. 2014; 35: 87-100.
15. Sethi S, Murphy TF,. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. NEJM 2008; 359: 2355-2365.
16. Tager I, Speizer FE,. Role of infection in chronic bronchitis. N. Engl. J. Med. 1975; 292: 563-571.
17. Sethi S,. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome? Ann. Am. Thorac. Soc. 2014; 11 (Suppl. 1): S43-47.
18. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI,. The human microbiome project. Nature 2007; 449: 804-810.
19. Nguyen LD, Viscogliosi E, Delhaes L,. The lung mycobiome: an emerging field of the human respiratory microbiome. Front. Microbiol. 2015; 6: 89.
20. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, Beck JM, Curtis JL, Huffnagle GB,. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 2015; 6: e00037.
21. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 2013; 187: 1067-1075.
22. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, Chen H, Berger KI, Goldring RM, Rom WN, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 2013; 1: 19. doi: 10.1186/2049-2618-1-19.
23. Cabrera-Rubio R, Garcia-Nunez M, Seto L, Anto JM, Moya A, Monso E, Mira A,. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J. Clin. Microbiol. 2012; 50: 3562-3568.
24. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC,. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1073-1080.
25. Millares L, Ferrari R, Gallego M, Garcia-Nunez M, Perez-Brocal V, Espasa M, Pomares X, Monton C, Moya A, Monso E,. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 2014; 33: 1101-1111.
26. Garcia-Nunez M, Millares L, Pomares X, Ferrari R, Perez-Brocal V, Gallego M, Espasa M, Moya A, Monso E,. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J. Clin. Microbiol. 2014; 52: 4217-4223.
27. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV,. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J. Clin. Microbiol. 2014; 52: 2813-2823.
28. Sethi S, Evans N, Grant BJ, Murphy TF,. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 2002; 347: 465-471.
29. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV,. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010; 14: 9-59.
30. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013; 188: 1224-1231.